Why The Drive For Medical Transition Should Be Re-Psychopathologized (#42)
9 October 2025
Global
Genspect — co-founded by Stella O'Malley — is calling for the re-psychopathologization of the drive toward extreme medical transition, and in this episode Stella and Mia Hughes set out exactly what that means. The episode traces a fifteen-year dismantling of psychiatric safeguards, from WPATH's 2010 declaration to the WHO's 2018 reclassification, and argues that Ireland is caught in the resulting vacuum. With no Cass-equivalent review, conversion therapy legislation in progress and gender clinics expanding, Irish clinicians and families urgently need the clinical framework this campaign is trying to restore.
Genspect, the international organisation co-founded by Stella O'Malley, has launched a campaign calling for the re-psychopathologization of the drive toward extreme medical transition. In this episode Stella and her co-host Mia Hughes explain precisely what that means and why they believe it is the most compassionate response available to clinicians working with distressed young people. The language is deliberately provocative. Psychopathologization carries decades of difficult history, and the episode is careful to separate two very different clinical pictures: a teenager who develops a trans identity is not exhibiting pathological behaviour; a teenager relentlessly fixated on removing healthy body parts and pursuing irreversible surgery is presenting a picture that demands proper mental health assessment. The episode traces a fifteen-year arc. In 2010 the World Professional Association for Transgender Health declared gender variance natural and healthy and called for the removal of psychiatric gatekeeping from transition-related care. By 2013 the DSM-5 had replaced Gender Identity Disorder with Gender Dysphoria, moving the identity outside clinical concern. In 2018 the WHO's ICD-11 went further, relocating gender incongruence out of the mental health chapter entirely. Stella and Mia argue that this sequence stripped clinicians of the conceptual tools they needed to protect vulnerable young people, triggering a period of social contagion in which ideological momentum replaced clinical judgement. For Irish listeners, this history is not merely academic. Ireland has been expanding provision of gender medicine for minors at precisely the moment when international scrutiny of that provision has intensified. The Cass Review in Britain found that the evidence base underpinning puberty blockers and cross-sex hormones for children was of poor quality, prompting significant NHS restructuring. Ireland has conducted no equivalent independent review. Parents, schools and GPs are navigating referral pathways without the transparent clinical appraisal that the Cass process attempted to provide, and conversion therapy legislation moving through the Oireachtas risks chilling the kind of exploratory therapeutic work this episode argues is most urgently needed. Stella speaks from the position of a practising Irish psychotherapist who encounters the downstream consequences of premature medical decisions in her work. Her argument is not that young people's distress should be dismissed or their identities denied. It is that distress deserves a thorough, unhurried clinical response — one that takes seriously the possibility of underlying mental health needs that might resolve without permanent physical alteration. The Genspect re-psychopathologization campaign is an attempt to give that argument institutional form at a moment when Irish medicine, politics and public life have yet to have the reckoning that other countries are beginning to undertake.
